ENCHANT
LIVE

Serial Number

98726753

Owner

Iambic Therapeutics, Inc.

Attorney

Alyssa M. Worsham

First Use Date

Sep 23, 2024

Filing Date

Aug 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENCHANT Trademark

Serial Number: 98726753

ENCHANT is a trademark filed by Iambic Therapeutics, Inc. on August 30, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Iambic Therapeutics, Inc. (5 trademarks)

5627 Oberlin Drive, Suite 120
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

August 30, 2024

Registration Date

Not Registered

First Use Anywhere

September 23, 2024

First Use in Commerce

September 23, 2024

Published for Opposition

May 27, 2025

Goods & Services

technical scientific consultation and product development for others in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; development of materials, software, artificial intelligence, chemicals, and pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; research and development of treatment protocols for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in science, chemistry, biology, physics, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, technology, chemical engineering, computer science, medicine and healthcare, and design and optimization of molecules, materials, catalysts, chemicals, and drugs; chemistry consultation services in the nature of drugs, materials, chemicals, and molecular discovery services; product development services; chemical research and chemistry consultation in the field of drug, materials, chemicals, and molecular development; providing online non-downloadable software for simulations for drug, materials, chemicals, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; software as a services (SAAS) services in the nature of hosting software for cloud-based computing for the development of new molecules and designing and discovering molecules, drugs, and other molecular products; research and development of pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; design and development of computer software; providing online non-downloadable computer software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; platform as a service (PAAS) featuring computer software platforms using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; platform as a service (PAAS) featuring artificial intelligence computer software platforms for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; software as a service (SAAS) featuring software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; software as a service (SAAS) featuring artificial intelligence software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; providing online non-downloadable computer software for scientific analysis; providing online non-downloadable software, namely, software for use in designing and developing artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, computational chemistry, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in determining properties or physical characteristics of organic compounds, inorganic compounds, organic materials, inorganic materials; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services; Industrial research services in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; Industrial analysis in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; computer modeling services; scientific research into organic compounds; scientific services, namely, analysis of organic compounds, inorganic compounds, organic materials, inorganic materials; crystal analysis services for scientific research purposes; research in the field of computer natural language processing; medical and scientific research in the field of machine learning and models to evaluate drug compounds pharmacological properties; medical and scientific research services in the field of machine learning models to evaluate bioactivity and pharmacological properties of drug compounds; medical and scientific research services in the field of machine learning models to generate and evaluate drug compounds for specific pharmacological and bioactivity effects and results; medical and scientific research services in the field of machine learning models to evaluate drug compounds and their efficacy and side effects for purposes of clinical trials; medical and scientific research services in the field of machine learning models to generate and evaluate treatment protocols for purposes of clinical trials

Filing History

STATEMENT OF USE PROCESSING COMPLETE
May 25, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 25, 2026 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2026 EXRA
USE AMENDMENT FILED
Jan 22, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 22, 2026 EISU
SOU EXTENSION 1 GRANTED
Jan 22, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 22, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 22, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 5, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2024 NWOS
NEW APPLICATION ENTERED
Aug 30, 2024 NWAP